Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.111043
Revised: July 23, 2025
Accepted: October 29, 2025
Published online: December 20, 2025
Processing time: 180 Days and 22.9 Hours
The heterogeneous group of disorders called peripheral vascular diseases (PVDs) occurs outside the heart and brain tissue to cause ischemia and severe health com
To evaluate skin biopsy applications in PVD diagnostics through artistic analysis of technical processes and exa
A systematic review of randomized controlled trials and original studies about skin biopsy utility in PVD diagnosis used PubMed, Scopus, and EMBASE search platforms. The reviewed studies met specific entry requirements, while all case reports and review articles remained excluded.
A total of 22 studies suited the research criteria that were evaluated. Researchers emphasized the value of skin biopsies for identifying inflammatory from non-inflammatory PVDs. At the same time, they detect systemic sclerosis and diabetic vasculopathy abnormalities of micro-vessels and identify endothelial dysfunction through measurements of vascular endothelial growth factor and intercellular adhesion molecule-1 and endothelial nitric oxide synthase markers. Skin biopsies require further improvement because they cause patient discomfort and produce variable diagnostic results that specialists must interpret.
Skin biopsies enable essential diagnostic findings about PVD and improve patient detection. The development of standardized biopsy procedures and molecular diagnosis techniques should be studied to advance PVD diagnoses in clinical practice.
Core Tip: The systematic review highlights the crucial role of skin biopsies in the diagnosis of peripheral vascular diseases, particularly in terms of histopathological and molecular investigations. The study of skin biopsies is highly informative in understanding diseases in terms of microvascular pathology, endothelial dysfunction, and inflammation, such as systemic sclerosis, diabetic vasculopathy, and vasculitis. The incorporation of molecular markers, such as vascular endothelial growth factor, intercellular adhesion molecule-1, and endothelial nitric oxide synthase, highlights the potential of skin biopsies in enhancing diagnostic accuracy and stratifying patients. Nonetheless, some difficulties related to the standardization of both biopsy and molecular testing remain, which necessitate additional studies to apply it in practice.
